scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(00)02222-4 |
P698 | PubMed publication ID | 10821370 |
P2093 | author name string | F C Breedveld | |
R B Landewé | |||
B A Dijkmans | |||
B E van den Borne | |||
P2860 | cites work | No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis | Q77539447 |
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis | Q35548424 | ||
Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. | Q41452120 | ||
Abnormal homocysteine metabolism in rheumatoid arthritis | Q61663327 | ||
P433 | issue | 9215 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | circulatory system | Q11068 |
methotrexate | Q422232 | ||
rheumatoid arthritis | Q187255 | ||
comorbidity | Q1414874 | ||
P304 | page(s) | 1616-1617 | |
P577 | publication date | 2000-05-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity | |
P478 | volume | 355 |
Q28188829 | A clinical and economic review of disease-modifying antirheumatic drugs |
Q51787678 | Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis. |
Q34601733 | Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? |
Q59329753 | An interpretable boosting model to predict side effects of analgesics for osteoarthritis |
Q37436281 | Assessment of left atrial mechanical functions and atrial electromechanical delay in Juvenile idiopathic arthritis by tissue Doppler echocardiography |
Q43578147 | Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study |
Q36253671 | Atherosclerosis and rheumatoid arthritis: more than a simple association |
Q35553376 | Atherosclerotic cardiovascular disease in rheumatoid arthritis |
Q35121150 | Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions |
Q37859676 | Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity |
Q33806651 | Cardiovascular morbidity and mortality in rheumatoid arthritis |
Q82835412 | Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model |
Q37956137 | Cardiovascular safety of biologic therapies for the treatment of RA. |
Q35198206 | Co-morbidity in rheumatoid arthritis |
Q34275967 | Comorbidity in rheumatoid arthritis. |
Q28364851 | Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area |
Q81346281 | Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease |
Q40408210 | Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy |
Q44574975 | Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity |
Q44016937 | Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis |
Q28190121 | Homocysteine-lowering treatment: an overview |
Q48502988 | Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis |
Q44652560 | Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis |
Q42019607 | Inflammatory bowel disease of the elderly: a wake-up call |
Q38122069 | Management of the elderly patients with inflammatory bowel disease: practical considerations. |
Q37975943 | Managing cardiovascular risk in patients with chronic inflammatory diseases. |
Q44973310 | Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study |
Q34757801 | Methotrexate in atherogenesis and cholesterol metabolism |
Q35471696 | Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells |
Q35636960 | Methotrexate modulates the kinetics of adenosine in humans in vivo |
Q27320563 | Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation |
Q35551023 | Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis |
Q80152218 | P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters |
Q38291820 | Prediction and management of cardiovascular outcomes in systemic lupus erythematosus |
Q28709376 | Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis |
Q36040885 | Rheumatoid disease and the heart: from epidemiology to echocardiography |
Q37640953 | The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review |
Q79394738 | The effects of folic acid and nitric oxide synthase inhibition on coronary flow and oxidative stress markers in isolated rat heart |
Q36596365 | The heart and cardiovascular manifestations in rheumatoid arthritis |
Q34717052 | Treatment of inflammatory bowel disease in the elderly: an update |
Q81881480 | Use of tissue Doppler and its comparison with other conventional Doppler techniques in the assessment of diastolic functions in patients with active rheumatoid arthritis |
Q87636756 | Use of tissue Doppler and its comparison with other pulse Doppler echocardiography in the evaluation of diastolic functions in patients with active juvenile idiopathic arthritis |
Q73559007 | Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study |
Q46407214 | Which factors are related to the presence of atherosclerosis in rheumatoid arthritis? |
Search more.